Germany Boosts Own Vaccine Makers in Race for COVID-19 Jab

Germany says it is providing up to 750 million euros to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus.

Science Minister Anja Karliczek said Tuesday that the government has already agreed to provide BioNTech and CureVac with 375 million euros and 230-million euros respectively to develop their mRNA-based vaccines.

Talks with a third company, IDT Biologika, are expected to conclude soon, she said. The company is developing a vector-based vaccine that delivers a coronavirus protein into cells to stimulate the body’s immune response.

The agreement with the three companies, which is tied to specific milestones, would guarantee Germany 40 million doses of vaccine. The amount comes on top of other vaccine supply agreements concluded through the European Union, of which Germany is a member.

Karliczek said Germany wouldn’t cut corners when it comes to testing vaccines, meaning most of the population may have to wait until mid-2021 to be inoculated.

“Safety is an absolute priority,” she said.

Health Minister Jens Spahn echoed that stance, saying that only vaccines which have been tested on “thousands, ideally many thousands of volunteers in phase 3” would be approved.

Spahn complained that reports from Russia and China about vaccines being developed in the two countries “aren’t always such that one feels there’s absolute transparency.”

Spahn dismissed suggestions that Germany might consider making COVID-19 vaccinations compulsory.

“We need 55-60% of the population to be vaccinated,” he said. “I’m firmly convinced we will achieve this voluntarily.”

Spahn added that Germany also doesn’t intend to hoard vaccines.

“I’m happy to give other countries in the world some of the vaccines we’re been contractually assured,” he said, “if we find in the end that we have more than we need.”

‹

‘Overwhelm the Problem’: Inside Biden’s War on COVID-19

The meetings begin each day not long after dawn. Dozens of aides report in, coffee in hand, joining by Zoom from agency headquarters, their homes or even adjacent offices. The sessions start with the latest sobering statistics meant to focus the work and offer a reminder of what’s at stake: new coronavirus cases, people in […]

3rd Major COVID-19 Vaccine Shown To Be Effective and Cheaper

Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are based on interim analysis of trials in the U.K. and […]

Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon

Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — last data needed to seek emergency use of limited shot supplies even as the catastrophic outbreak worsens across the globe. The announcement from Pfizer and its German partner […]

Biden Seeks Window on Vaccine Plans as Trump Stalls Handoff

President-elect Joe Biden’s scientific advisers plan to meet with vaccine makers in coming days even as a stalled presidential transition keeps them out of the loop on government plans to inoculate all Americans against COVID-19. President Donald Trump’s refusal to accept that he lost the election means that the Biden team lacks a clear picture of the groundwork within […]

Pfizer Says COVID-19 Vaccine Is Looking 90% Effective

Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration. The announcement, less than a week after a presidential election […]

2nd COVID-19 Vaccine Trial Paused Over Unexplained Illness

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” […]

Late-Stage Study of First Single-Shot Vaccine Begins in U.S.

Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study starting Wednesday will be one of the world’s largest coronavirus vaccine studies so far, testing the shot in 60,000 volunteers in the U.S., South Africa, Argentina, Brazil, Chile, Colombia, Mexico […]

As Rich Nations Struggle, Africa’s Virus Response Is Praised

At a lecture to peers this month, John Nkengasong showed images that once dogged Africa, with a magazine cover declaring it “The Hopeless Continent.” Then he quoted Ghana’s first president, Kwame Nkrumah: “It is clear that we must find an African solution to our problems, and that this can only be found in African unity.” […]

U.S. Outlines Sweeping Plan to Provide Free COVID-19 Vaccines

The federal government outlined a sweeping plan Wednesday to make vaccines for COVID-19 available for free to all Americans, even as polls show a strong undercurrent of skepticism rippling across the land. In a report to Congress and an accompanying “playbook” for states and localities, federal health agencies and the Defense Department sketched out complex […]

Germany Boosts Own Vaccine Makers in Race for COVID-19 Jab

Germany says it is providing up to 750 million euros to support three domestic pharmaceutical companies that are developing vaccines against the new coronavirus. Science Minister Anja Karliczek said Tuesday that the government has already agreed to provide BioNTech and CureVac with 375 million euros and 230-million euros respectively to develop their mRNA-based vaccines. Talks […]

›